Contact: info@alspinc.com
Neurodegenerative Conditions increase with advancing age...
 
1 in 3 individuals over 80 risk Alzheimer's disease 
1 in 100 individuals over 85 risk Parkinson's disease 
1 in 10,000 risk Huntington's disease
 
...TBI increases risk of dementia
by as much as two-fold
 
Neurodegenerative Conditions increase with advancing age...
 
1 in 3 individuals over 80 risk Alzheimer's disease 
1 in 100 individuals over 85 risk Parkinson's disease 
1 in 10,000 risk Huntington's disease
 
...TBI increases risk of dementia
by as much as two-fold
 
Neurodegenerative Conditions increase with advancing age...
 
1 in 3 individuals over 80 risk Alzheimer's disease 
1 in 100 individuals over 85 risk Parkinson's disease 
1 in 10,000 risk Huntington's disease
 
...TBI increases risk of dementia
by as much as two-fold
 
vvvNeurodegenerative Conditions increase with advancing age...
 
1 in 3 individuals over 80 risk Alzheimer's disease 
1 in 100 individuals over 85 risk Parkinson's disease 
1 in 10,000 risk Huntington's disease
 
...TBI increases risk of dementia
by as much as two-fold
 




ALSP Inc. is led by a dedicated team of experienced executives, scientists and thought leaders that have extensive business and clinical experience in drug development.


Neurodegenerative Conditions increase with advancing age...
 
1 in 3 individuals over 80 risk Alzheimer's disease 
1 in 100 individuals over 85 risk Parkinson's disease 
1 in 10,000 risk Huntington's disease
 
...TBI increases risk of dementia
by as much as two-fold
 

ALSP Inc. Management Team

 

Michael D.Pierschbacher, Ph.D.

President and Chief Executive Officer

Steven Jacobsen, Ph.D.

Sr. Vice President and Chief Scientific Officer


Gregory Hook, Ph.D., J.D.

Co-Founder, Vice President Research, and Corporate Counsel



Robert J. Ternansky, Ph.D.

Vice President, Medicinal Chemistry


Gregory P. Einhorn, Ph.D., J.D.

Vice President, Intellectual Property


< Back

 

Gregory Hook, Ph.D., J.D.

Co-Founder, Vice President Research, and Corporate Counsel

 

Gregory Hook, Ph.D., J.D., is a Co-Founder of ALSP Inc. He previously served as a Patent Advisor to Diversa Corporation, San DiegoCA.

 

Earlier Dr. Hook served as a biotechnology patent attorney with the law firm of Campbell & Flores, in San Diego, and a Patent Examiner in the pharmaceutical arts at the United States Patent and Trademark Office, in Crystal City, VA. He also served as Scientist at the Naval Medical Research Institute, in BethesdaMaryland, a Staff and Senior Staff Fellow at the National Institutes of Health, Bethesda, Maryland, and a Post-doctoral Fellow at the Johns Hopkins University, Baltimore, Maryland. 

 

Dr. Hook holds a Ph.D. in Biophysics and a B.A. in Medical Physics from the University of CaliforniaBerkeley and a J.D. in the intellectual Property Tract from George Mason University.